The company’s stock rose in its first two days on public markets, closing on Monday up almost 58% over the IPO price amid ...

Abbott and Boston Scientific are among the investors in SetPoint, whose neurostimulation device gained FDA approval last ...

The update covers devices used in procedures to implant the company’s Watchman heart device.

A company spokesperson said in a statement to MedTech Dive that direct causation between the deaths and calcification of the ...

Edwards Lifesciences and JenaValve said they remained committed to completing the deal and would defend the case in court.

The company said it has grown capacity by 10% this year, bringing its total U.S. output of the prefilled flush syringes to ...

CFO Suketu Upadhyay said the company now expects a charge in 2025 of about $40 million, compared with a range of $60 million ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

CEO Christian Mazzi said the minimally invasive surgical technique could provide better outcomes for patients than ...

The U.S. alleged the company knowingly sold genetic-sequencing systems with software vulnerabilities to federal agencies.

BTIG analyst Ryan Zimmerman called the transaction “a solid deal” for Alcon given STAAR’s struggles in the China market.

Executives also said demand for capital equipment continues to be healthy. However, investors may have expected stronger ...